✦ LIBER ✦

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

✍ Scribed by Targan, Stephan R.; Hanauer, Stephen B.; van Deventer, Sander J.H.; Mayer, Lloyd; Present, Daniel H.; Braakman, Tanja; DeWoody, Kimberly L.; Schaible, Thomas F.; Rutgeerts, Paul J.

Book ID: 120070325
Publisher: Massachusetts Medical Society
Year: 1997
Tongue: English
Weight: 105 KB
Volume: 337
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJM199710093371502

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term efficacy of chimeric monoclon

Short-term efficacy of chimeric monoclonal antibody cA2 to tumor necrosis factor α for refractory, fistulizing Crohn's disease

✍ S. Bollani; S. Ardizzone; E. Colombo; V. Imbesi; G. Bianchi Porro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Short-term efficacy of chimeric monoclon

Short-term efficacy of chimeric monoclonal antibody cA2 to tumor necrosis factor a for refractory, fistulizing Crohn's disease

✍ Ardizzone, Sandra; Bollani, Simona; Colombo, Elisabetta; Imbesi, Venerina; Bianc 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Mechanism and Therapeutic Strategy of Se

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-a Monoclonal Antibody Treatment for Crohn's Disease

✍ Matsuoka, Katsuyoshi; Kanai, Takanori 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 97 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Unexpected dramatic clinical response of

Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor (tnfalpha) monoclonal antibody for Crohn’s Disease

✍ Leslie Bank∗; Belinda Hunt 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

The effect of monoclonal anti-tumor necr

The effect of monoclonal anti-tumor necrosis factor-antibody cA2 on coagulation- and fibrinolytic parameters in patients with active Crohn's disease: D.W. Hommes, H.M. van Dullemen, J. Meenan, A. van den Ende, J. Woody, G.N.J. Tytgat, S.J.H. van Deventer. Center for Thrombosis, Hemostasis, Atherosclerosis and Inflammation Research, Dept. of Gastroenterology, University of Amsterdam, Amsterdam, the Netherlands

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 177 KB